ICLR

ICON plc (ICLR) | Rumor.io

ICON

ICLR

Attention (50-day avg)0%

Attention rank (50-day avg)#2,185

Bullish sentiment (50-day avg)100%

Price to earnings ratio267.6

Market capitalization13.5B

Earnings per share0.65

Dividend yield (TTM)—

Revenue (annual)8.3B

Net income (annual)229.3M

Social

What share of all stock conversation is about ICLR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% +0	0% 0

Jun 29

ICON Public Limited Company's stock ($ICLR) rose 16% last week, making it a standout in European markets.
The company's stock outperformed its peers, gaining significant attention in the market.
No further information is available as the post does not provide any additional context or details.

Generated by AI

Sentiment

Of the messages about ICLR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	20.33% -57.67
Bearish	—	—	—	79.67% +57.67

Bullish· Feb 13

$ICLR has shown strong momentum, with buyers not letting it pull back much, indicating a continued upward trend.
ICON Public Limited Company has a strong market position and cash flow, making it an attractive long-term opportunity despite a recent drop.
Analysts, including Baird and DB, have designated $ICLR as a bullish pick, with DB also highlighting a potential price target of $160.

Bearish· Feb 12

$ICLR's stock price has plummeted due to a voluntary internal audit revealing potential accounting issues, with some investors comparing the situation to an SEC or DOJ investigation.
The company's revenue may have been overstated by less than 2% in the past two fiscal years, a figure that some consider insignificant given the company's size and profitability.
The market reaction to the news has been severe, with the stock price experiencing a massive drop of over 40% and some analysts warning of a potential 50% haircut, although others believe the sell-off may be overdone.

Generated by AI

Topics

Of the messages about ICLR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	0%	36.04%	57.36%
Technical Analysis	—	100%	63.96%	16.95%
Analysts	—	0%	0%	14.38%
Earnings	—	0%	0%	5.14%
Macro	—	0%	0%	6.16%
Controversies	—	0%	0%	0%

Earnings· Jul 25

ICON Public Limited Company beats earnings estimates by $0.03 and exceeds revenue expectations.
The company reports FQ2 earnings of $1.54 EPS and $641.61M in revenue.
ICON raises FY18 guidance, remaining in line with the midpoint above consensus estimates.

Analysts· Jul 27

Deutsche Bank raised Icon's price target to $170.00 and maintains a "Hold" rating.
Several analysts, including UBS Group and Mizuho, have increased Icon's price target to $194.00 and $195.00, respectively.
Icon's price target has been boosted by multiple analysts, including Jefferies Financial Group, which raised its target to $220.00.

Announcements· Jul 23

ICON Public Limited Company reported second quarter 2025 results.
$ICLR revenue and earnings were not specified in the announcement.
The company released its quarterly earnings report.

Generated by AI

Community

Of the messages about ICLR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	95.95%	30.08%	24.81%
Newcomers	—	4.05%	69.92%	75.19%

Regulars· Jul 22

$ICLR has increased by 14% today and is up over 25% since entry, with a share price rising from $128 to $160 in over a month.
The stock is considered "very cheap" by regular participants, who believe it can easily return to $200 or higher.
This post is part of a longer-term focus on $ICLR, with the regulars having been following its progress since entry.

Newcomers· Jul 28

The newcomer is focusing on the strong volume surge and RSI spike as indicators of momentum in ICLR's stock price.

Generated by AI

Marram Investment Management’s second-quarter 2026 investor letter reports a +2.7% portfolio return (net of fees), resulting in a year-to-date return of +3.2%. A copy of the letter can be downloaded here. Cumulatively, since inception, the firm has achieved a +632.4% return and a +13.7% annualized return, net of fees. Positive contributions came from MLP Energy […]

7d agoYahoo Finance

S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag

12d agoBarron's

Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?

Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

1mo agoYahoo Finance

Insider Selling: Linda Grais Unloads $138K Of Icon Stock

1mo agoBenzinga

ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity

Greenskeeper Asset Management, an independent firm that specializes in disciplined value investing, recently released its Q2 2026 scorecard. A copy is available to download here. After a slow start to the year, the Fund gained 10.9% in the quarter, lifting its year-to-date return to 1.9%. The rebound came as markets showed signs of rotating away from momentum […]

1mo agoYahoo Finance

ICON Announces Private Offering of Notes

DUBLIN, August 04, 2026--ICON Announces Private Offering of Notes

1mo agoYahoo Finance

Also Discussed

Investors talking about ICLR also mention

#	Name	Attention
1	Medpace Holdings, Inc.MEDP	0%+0
2	IQVIA Holdings Inc.IQV	0%0
3	Aurora Innovation, Inc. WarrantAUROW	0%-0.01
4	Heritage Global Inc.HGBL	0%0
5	Charles River Laboratories International, Inc.CRL	0%new
6	Installed Building Products, Inc.IBP	0%0
7	Patrick Industries, Inc.PATK	0%0
8	Lyell Immunopharma, Inc.LYEL	0.01%new
9	Global X Copper Miners ETFCOPX	0.07%+0.05
10	Stevanato Group S.p.A.STVN	0%0

ICON plc

Healthcare
Diagnostics & Research

ICON plc is a clinical research organisation that provides outsourced drug and device development services to pharmaceutical, biotechnology, medical device, and public health customers. The company supports clinical development across the full product lifecycle, including study design, trial management, data solutions, site and patient access, laboratory services, and commercialization support. ICON plc also offers consulting and advisory capabilities, decentralized and hybrid trial services, real-world intelligence, and therapeutic expertise across areas such as oncology, cardiology, infectious disease, immunology, and central nervous system disorders. Its work is used to help clients run clinical programs more efficiently and bring medical treatments through development and approval pathways. Headquartered in Dublin, Ireland, ICON plc operates through a broad international network and serves organizations in multiple global markets.

Website

Location

South County Business Park

Dublin, D18 X5R3

Ireland

Social

What share of all stock conversation is about ICLR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% +0	0% 0

Jun 29

ICON Public Limited Company's stock ($ICLR) rose 16% last week, making it a standout in European markets.
The company's stock outperformed its peers, gaining significant attention in the market.
No further information is available as the post does not provide any additional context or details.

Generated by AI

Sentiment

Of the messages about ICLR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	20.33% -57.67
Bearish	—	—	—	79.67% +57.67

Bullish· Feb 13

$ICLR has shown strong momentum, with buyers not letting it pull back much, indicating a continued upward trend.
ICON Public Limited Company has a strong market position and cash flow, making it an attractive long-term opportunity despite a recent drop.
Analysts, including Baird and DB, have designated $ICLR as a bullish pick, with DB also highlighting a potential price target of $160.

Bearish· Feb 12

$ICLR's stock price has plummeted due to a voluntary internal audit revealing potential accounting issues, with some investors comparing the situation to an SEC or DOJ investigation.
The company's revenue may have been overstated by less than 2% in the past two fiscal years, a figure that some consider insignificant given the company's size and profitability.
The market reaction to the news has been severe, with the stock price experiencing a massive drop of over 40% and some analysts warning of a potential 50% haircut, although others believe the sell-off may be overdone.

Generated by AI

Topics

Of the messages about ICLR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	0%	36.04%	57.36%
Technical Analysis	—	100%	63.96%	16.95%
Analysts	—	0%	0%	14.38%
Earnings	—	0%	0%	5.14%
Macro	—	0%	0%	6.16%
Controversies	—	0%	0%	0%

Earnings· Jul 25

ICON Public Limited Company beats earnings estimates by $0.03 and exceeds revenue expectations.
The company reports FQ2 earnings of $1.54 EPS and $641.61M in revenue.
ICON raises FY18 guidance, remaining in line with the midpoint above consensus estimates.

Analysts· Jul 27

Deutsche Bank raised Icon's price target to $170.00 and maintains a "Hold" rating.
Several analysts, including UBS Group and Mizuho, have increased Icon's price target to $194.00 and $195.00, respectively.
Icon's price target has been boosted by multiple analysts, including Jefferies Financial Group, which raised its target to $220.00.

Announcements· Jul 23

ICON Public Limited Company reported second quarter 2025 results.
$ICLR revenue and earnings were not specified in the announcement.
The company released its quarterly earnings report.

Generated by AI

Community

Of the messages about ICLR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	95.95%	30.08%	24.81%
Newcomers	—	4.05%	69.92%	75.19%

Regulars· Jul 22

$ICLR has increased by 14% today and is up over 25% since entry, with a share price rising from $128 to $160 in over a month.
The stock is considered "very cheap" by regular participants, who believe it can easily return to $200 or higher.
This post is part of a longer-term focus on $ICLR, with the regulars having been following its progress since entry.

Newcomers· Jul 28

The newcomer is focusing on the strong volume surge and RSI spike as indicators of momentum in ICLR's stock price.

Generated by AI

ICON

Social

Jun 29

Bullish· Feb 13

Bearish· Feb 12

Earnings· Jul 25

Analysts· Jul 27

Announcements· Jul 23

Regulars· Jul 22

Newcomers· Jul 28

ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure

S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag

Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?

Insider Selling: Linda Grais Unloads $138K Of Icon Stock

ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity

ICON Announces Private Offering of Notes

Also Discussed

ICON plc

Company Information

Location

ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure

S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag

Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?

Insider Selling: Linda Grais Unloads $138K Of Icon Stock

ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity

ICON Announces Private Offering of Notes

Also Discussed

Social

Jun 29

Bullish· Feb 13

Bearish· Feb 12

Earnings· Jul 25

Analysts· Jul 27

Announcements· Jul 23

Regulars· Jul 22

Newcomers· Jul 28